General Updates

1 July 2026 To To The Secretary, The Manager, Listing Department, Listing Department, BSE Limited, The National Stock Exchange of India Ltd, 1st Floor, Phiroze Jeejeebhoy Towers, Exchange Plaza, Bandra Kurla Complex, Dalal Street, Mumbai 400001. Bandra (East), Mumbai 400051. Scrip Code: 540975 Scrip Symbol: ASTERDM Dear Sir/ Madam, Sub: Scheme of Amalgamation between Quality Care India Limited (‘QCIL’ / ‘Transferor Company’) and Aster DM Healthcare Limited (‘Aster’ / ‘Transferee Company’) and their respective Shareholders and Creditors (‘the Scheme’) Ref: Our letter dated 25 June 2026 and Regulation 30 read with Schedule III of SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015 (“Listing Regulations”) With reference to the subject captioned, we the Merged Company i.e., Aster DM Quality Care Limited, w.e.f. the Effective Date, subject to receipt of fresh certificate of incorporation (currently as Aster DM Healthcare Limited), wish to inform you as following: 1. Intimation of ‘Effective Date’ of the Scheme: Pursuant to the applicable provisions of the Companies Act, 2013 & clause E(m) of part I of the Scheme and in terms of the approval of Board of Directors of Aster and QCIL, both the companies have filed e-Form INC-28 with the Registrar of Companies, Telangana, on 26 June 2026 and having completed all the other conditionalities for effectiveness , and in accordance with the Scheme, the Scheme has become effective from today i.e., Wednesday, 1 July 2026, being the first day of the calendar month immediately following the calendar month in which all conditionalities mentioned in Clause 24 of the Scheme are completed. 2. Change in Promoter category: Consequent to the Scheme, BCP Asia II Topco IV Pte. Limited has been categorized as a promoter shareholder of the Company with effect from 1 July 2026. 3. Amendment in the Memorandum of Association (MOA) and Article of Association (AOA) of the Company: Pursuant to clause E(m) of part I of the Scheme and 1 July 2026 being the effective date for the Scheme, the Memorandum of Association and Article of Association of the Company stand amended with effect from 1 July 2026, in accordance with the Scheme as approved by the shareholders of the Company and the NCLT, on 10 March 2026 and 19 June 2026, respectively. Briefs of the amendments are as follows: a. name of the Company has changed from 'Aster DM Healthcare Limited' to 'Aster DM Quality Care India Limited' with effect from 1 July 2026, subject to receipt of fresh 'Certificate of Incorporation pursuant to change of name' to be issued by the Registrar of Companies (RoC-Telangana). b. the Capital Clause of the MOA of Company stands amended as: “The authorised share capital of the company is INR 1,051,70,00,000/- (Indian Rupees One Thousand and Fifty One Crores and Seventy Lakhs only) divided into 98,20,00,000 (ninety eight crores and twenty lakhs ) equity shares of the face value of Indian rupees 10/- (Indian Rupees Ten only) each, 35,00,000 (thirty five lakh) Preference Shares of INR 10/- (Indian Rupees Ten Only) each and 1,52,00,000 (one crore and fifty two lakhs) Series A compulsorily convertible preference shares of the face value of INR 10/- (Indian Rupees Ten only) each and 5,10,00,000 (five crores ten lakhs) RAR compulsorily convertible preference shares of the face value of INR 10/- (Indian Rupees Ten only) each” c. the AOA of the Company amended as set out under the Scheme. A copy of the updated MOA and AOA of the Company is available on the website of the Company at www.asterdmhealthcare.in We request you to kindly take the above information on record. Thanking you, For Aster DM Healthcare Limited Hemish Purushottam Company Secretary and Compliance Officer M. No. A24331